Search

everythinglearnresearchcommunity

for

Search:↓

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Trichotillomania was successfully treated with risperidone and naltrexone.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

Valproic acid is effective but often causes side effects like weight gain and hair loss, so personalized treatment is needed.

Upadacitinib may cause hair loss.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.